| 229 | 13 | 137 |
| 下载次数 | 被引频次 | 阅读次数 |
目的:观察清幽2号方联合四联疗法治疗幽门螺杆菌(Hp)相关慢性胃炎的临床疗效。方法:采用随机数字表法,将90例Hp阳性慢性胃炎脾胃湿热证患者分为对照组和联合组各45例。对照组予常规四联药物口服治疗2周,联合组予常规四联药物联合清幽2号方口服治疗,两组四联药物用法、用量及疗程均一致,清幽2号方口服6周,即在停用四联药物后继服中药汤剂4周。观察两组治疗前后中医证候积分、Hp根除率、病变黏膜分级疗效、血清炎症因子水平、安全性及停药半年后Hp复发率。结果:治疗后,联合组中医证候积分、Hp根除率、病变黏膜分级疗效、血清炎症因子水平、停药半年后Hp复发情况均优于对照组(P<0.05)。对照组和联合组的不良反应发生率分别为4.44%、0.00%,两组比较差异无统计学意义(P>0.05)。结论:清幽2号方联合四联疗法治疗Hp相关慢性胃炎疗效确切,能修复受损黏膜、改善患者临床症状、提高Hp根除率、降低血清炎症因子水平等,且安全性较高。
Abstract:Objective :To explore the clinical efficacy of Qingyou No.2 Formula ( 清 幽 2 号 方 ) combined with quadruple therapy in treatment of helicobacter pylori(Hp) related chronic gastritis. Methods:A total of90 cases of Hp positive chronic gastritis with spleen stomach damp heat syndrome were randomly divided into the control group and the combined group,with 45 cases in each group. The control group was treated with conventional quadruple bactericide for 2 weeks,and the combined group was treated with the traditional quadruple bactericide combined with Qingyou No.2 Formula. The usage,dosage and course of treatment of the two groups were the same. Qingyou No.2 Formula was taken orally for6 weeks,that is,after stopping the use of the quadruple bactericide,the formula was taken for 4 weeks. Before and after treatment,traditional Chinese medicine(TCM) symptom score,Hp eradication rate,curative effect of pathological mucosa grading,serum inflammatory factor level,safety and Hp recurrence rate after half a year of drug withdrawal were observed.Results:After treatment,the TCM symptom score,Hp eradication rate,pathological mucosal grading effect,serum inflammatory factor level and Hp recurrence after half a year of drug withdrawal in the combined group were better than those in the control group(P <0.05). The incidence of adverse reactions in the control group and the combined group were 4.44% and 0.00%,the difference between the two groups was not statistically significant(P>0.05). Conclusions:Qingyou No.2 Formula combined with quadruple therapy is effective in the treatment of Hp related chronic gastritis. It can repair the damaged mucosa,improve the clinical symptoms,promote the eradication rate of Hp,and reduce the level of serum inflammatory factors,etc.,and it is with higher safety.
[1]杨成,崔梅花.幽门螺杆菌致病因子及其致病机制研究进展[J].世界华人消化杂志,2017,25(10):857-864.
[2]周雪亮,周渊,朱强,等.幽门螺旋杆菌的研究进展[J].中国继续医学教育,2018,10(33):101-104.
[3]沈丽莲.幽门螺杆菌感染相关性胃病中医药研究进展[J].辽宁中医药大学学报,2013,15(7):257-259.
[4]陶飞宝,叶旭星,何钦,等.慢性胃炎Hp感染、胃黏膜改变与中医证型的相关性[J].浙江中西医结合杂志,2019,29(6):473-475.
[5]房静远,杜奕奇,刘文忠,等.中国慢性胃炎共识意见(2017年,上海)[J].胃肠病学,2017,22(11):670-687.
[6]张声生,唐旭东,黄穗平,等.慢性胃炎中医诊疗专家共识意见(2017)[J].中华中医药杂志,2017,32(7):3060-3064.
[7]刘文忠,谢勇,陆红,等.第五次全国幽门螺杆菌感染处理共识报告[J].胃肠病学,2017,22(6):346-360.
[8]郑筱萸.中药新药临床研究指导原则:试行[M].北京:中国医药科技出版社,2002:124-129.
[9]张澍田.慢性胃炎的分类及内镜诊断标准[J].中国消化内镜,2007,1(4):15-19.
[10]张万岱,陈治水,危北海.慢性胃炎的中西医结合诊治方案(草案)[J].中国中西医结合杂志,2005,25(2):172-175.
[11] RAHAJOE P S,SMIT M J,KERTIA N,et al. Cytokines in gingivocrevicular fluid of rheumatoid arthritis patients:a review of the literature[J]. Oral Dis,2019,25(6):1423-1434.
[12] JUNG J Y,KIM J W,KIM H A,et al. Rituximab biosimilar CT-P10 for the treatment of rheumatoid arthritis[J].Expert Opin Biol Ther,2019,19(10):979-986.
[13]王文莉,万青,戴卉.石斛养胃汤联合西药治疗慢性萎缩性胃炎的临床效果[J].中国医药导报,2020,17(2):139-143.
[14]王文文,吴春媛,赵蜀崖. IL-8基因多态性与幽门螺旋杆菌易感性的相关研究[J].海南医学,2013,24(16):2344-2345.
[15]胡诚毅,莫志贤.黄连素的药理作用及机制研究进展[J].中国实验方剂学杂志,2017,23(20):213-219.
[16]毛宇,徐芳,徐小娟,等.白花蛇舌草抗肿瘤成分及其作用机理研究进展[J].现代预防医学,2015,42(17):3128-3132.
[17]何雨柔,黄玉迪,林培伟,等.蒲公英抗肿瘤作用的研究进展[J].肿瘤药学,2019,9(3):370-374.
[18]连大卫,许艺飞,任文康,等.广藿香醇抑制幽门螺杆菌脲酶活性及其机制[J].中国中药杂志,2017,42(3):562-566.
[19]左军,牟景光,胡晓阳.半夏化学成分及现代药理作用研究进展[J].辽宁中医药大学学报,2019,21(9):26-29.
[20]梁志培.茯苓化学成分、药理作用及临床应用研究进展[J].中国城乡企业卫生,2018,33(8):51-53.
[21]上官艳妮,李林,潘胤池,等.白及组织培养及其药理作用的研究进展[J].时珍国医国药,2019,30(7):1706-1709.
[22] YUE L, WANG W, WANG Y, et al. Bletilla striata polysaccharide inhibits angiotensin II-induced ROS and inflammation via NOX4 and TLR2 pathways[J]. Int J Biol Macromol,2016(89):376-388.
[23]舒尊鹏,胡书法,翟亚东,等.中药枳壳化学成分及药理作用研究[J].科技创新与应用,2012(17):8-9.
[24]王晶,张世洋,盛永成,等.白术治疗胃肠道疾病药理作用研究进展[J].中华中医药学刊,2018,36(12):2854-2858.
[25] KIM J Y,PARK S J,YUN K J,et al. Isoliquiritigenin isolated from the roots of glycyrrhizauralensis inhibits LPS-induced iNOS and COX-2 expression via the attenuation of NF-kappaB in RAW 264.7 macrophages[J].Eur J Pharmacol,2008,584(1):175-184.
[26]张玉龙,王梦月,杨静玉,等.炙甘草化学成分及药理作用研究进展[J].上海中医药大学学报,2015,29(3):99-102.
[27]王涵,林红强,谭静,等.党参药理作用及临床应用研究进展[J].世界最新医学信息文摘,2019,19(7):21-22,24.
基本信息:
DOI:10.16295/j.cnki.0257-358x.2022.06.008
中图分类号:R573.3
引用信息:
[1]穆琳琳,贾苏杰,马明鑫,等.清幽2号方联合四联疗法治疗Hp相关慢性胃炎临床研究[J],2022,41(06):620-625.DOI:10.16295/j.cnki.0257-358x.2022.06.008.
基金信息:
河北省重点研发计划项目(编号:18277775D)
2021-03-17
2021
2021-04-06
2021
1